Tricia A Moo-Young

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. doi Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer
    Tricia A Moo-Young
    Laboratory for Biologic Cancer Therapy, Department of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA
    J Immunother 32:12-21. 2009
  2. ncbi Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma
    Udaya K Liyanage
    Laboratory for Biologic Cancer Therapy, Department of Surgery and Alvin J Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA
    J Immunother 29:416-24. 2006
  3. doi Sporadic and familial medullary thyroid carcinoma: state of the art
    Tricia A Moo-Young
    Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
    Surg Clin North Am 89:1193-204. 2009

Collaborators

Detail Information

Publications3

  1. doi Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer
    Tricia A Moo-Young
    Laboratory for Biologic Cancer Therapy, Department of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA
    J Immunother 32:12-21. 2009
    ..Collectively, these observations further support the role of TGF-beta in the induction of Treg in pancreas adenocarcinoma...
  2. ncbi Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma
    Udaya K Liyanage
    Laboratory for Biologic Cancer Therapy, Department of Surgery and Alvin J Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA
    J Immunother 29:416-24. 2006
    ..We conclude that Pan02 tumor promotes the prevalence of Treg, in part through the secretion of TGF-beta, which may result in immune evasion...
  3. doi Sporadic and familial medullary thyroid carcinoma: state of the art
    Tricia A Moo-Young
    Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
    Surg Clin North Am 89:1193-204. 2009
    ..New systemic therapies for metastatic disease are being investigated. Targeted molecular therapies, based on knowledge of the pathways affected by RET mutations, are being tested in multiple clinical trials...